NCT00170781View on ClinicalTrials.gov

Efficacy and Safety of Lumiracoxib 400 mg Once Daily in Acute Flares of Gout

PHASE4CompletedINTERVENTIONAL

Enrollment

234

Participants

Timeline

Start Date

June 30, 2005

Conditions

Acute Gouty Arthritis

Interventions

DRUG

Lumiracoxib

Trial Locations (2)

4002

For Site Information, contact Novartis Pharma AG, Basel

Unknown

Novartis, Nuremberg

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Novartis

INDUSTRY